Correlation Between Apogee Therapeutics, and AMREP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and AMREP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and AMREP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and AMREP, you can compare the effects of market volatilities on Apogee Therapeutics, and AMREP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of AMREP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and AMREP.

Diversification Opportunities for Apogee Therapeutics, and AMREP

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Apogee and AMREP is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and AMREP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AMREP and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with AMREP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AMREP has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and AMREP go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and AMREP

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the AMREP. In addition to that, Apogee Therapeutics, is 1.15 times more volatile than AMREP. It trades about -0.24 of its total potential returns per unit of risk. AMREP is currently generating about -0.22 per unit of volatility. If you would invest  2,988  in AMREP on November 28, 2024 and sell it today you would lose (426.00) from holding AMREP or give up 14.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  AMREP

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
AMREP 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days AMREP has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Apogee Therapeutics, and AMREP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and AMREP

The main advantage of trading using opposite Apogee Therapeutics, and AMREP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, AMREP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AMREP will offset losses from the drop in AMREP's long position.
The idea behind Apogee Therapeutics, Common and AMREP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets